The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C
2
-C
5
)alkylene radical which is unsubstituted or substituted one or more times by an Alk group; R
1
represents a phenyl, a naphthyl, a pyridyl, a 1-benzothienyl or a 1,3-benzodioxolyl; R
2
represents a hydrogen atom, a halogen atom, an Alk group, an OAlk group or else a group chosen from —S-Alk, —SO-Alk, —SO
2
-Alk, —CO—N(R
4
)-Alk, —N(R
4
)SO
2
-Alk, —N(R
4
)CO-Alk, —N(R
4
)SO
2
—N(Alk)
2
; R
3
represents a hydrogen atom, a halogen atom, an Alk group or an OAlk group; R
4
represents a hydrogen atom or a (C
1
-C
4
)alkyl; Alk represents an unsubstituted or substituted (C
1
-C
4
)alkyl. Preparation process and therapeutic application.
本发明的主题是符合以下式(I)的化合物:其中:X代表未取代或通过一个或多个Alk基团取代的二价(C2-C5)烷基基团;R1代表
苯基、
萘基、
吡啶基、1-
苯并噻吩基或1,3-
苯并二
噁唑基;R2代表
氢原子、卤原子、Alk基团、
OAlk基团或从中选择的一种基团,包括—S-Alk、—SO-Alk、—SO2-Alk、—CO—N(R4)-Alk、—N(R4)SO2-Alk、—N(R4)CO-Alk、—N(R4)SO2—N(Alk)2;R3代表
氢原子、卤原子、Alk基团或
OAlk基团;R4代表
氢原子或(C1-C4)烷基;Alk代表未取代或取代的(C1-C4)烷基。制备过程和治疗应用。